Addressing the Cancer Burden in South America and the US Hispanic and Native American Populations through Clinical Trials

通过临床试验解决南美洲以及美国西班牙裔和美洲原住民人口的癌症负担

• 批准号: 9759602
• 负责人: JOHN J CROWLEY
• 金额: $ 1.5万
• 依托单位: CANCER RESEARCH AND BIOSTATISTICS (CRAB)
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-07-01 至 2021-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9759602
• 关键词: Address; Adolescent; Area; Cancer Burden; Chile; Clinical Oncology; Clinical Trials; Clinical Trials Design; Collaborations; Colombia; Country; Development; Future; Goals; Health; Health Professional; Hispanic Americans; Institutes; Institution; Latin America; Latin American; Lead; Malignant Neoplasms; Mexico; Mission; National Cancer Institute; National Clinical Trials Network; Native Americans; Output; Participant; Patients; Peru; Population; Prevention; Protocols documentation; Research; Research Personnel; Rest; South America; Southwest Oncology Group; System; Translating; Underrepresented Populations; Underserved Population; cancer clinical trial; cancer therapy; clinical infrastructure; collaborative trial; design; improved; innovation; insight; interest; novel; oncology; programs; research clinical testing; survivorship; symposium; symptom management; young adult

SUMMARY The purpose of this conference is to support a high quality scientific forum addressing the cancer burden in South America with the aim of generating studies to address that burden, with results that are potentially generalizable and applicable to the US Hispanic and Native American populations. This underserved population will be significantly represented by investigators from the host country, from the rest of South America, and from Mexico and the US. Experts in the design, conduct and analysis of clinical trials in oncology will join with healthcare professionals and institutional leaders to conduct a conference at a host country in South America, delivering a program that: (1) identifies the cancer burden in South America and explores what issues are unique to that continent, which generalize to the rest of Latin America, and which are also applicable to the US Hispanic and Native American population; (2) discusses the infrastructure for clinical trials in the region, the opportunities and challenges to collaborative trials with the US, and the current and possible future systems for multi‐ institution trials in the hemisphere; (3) shares ideas on innovative clinical trial design, conduct and analyses; (4) prioritizes possible collaborative projects and explores mechanisms for accomplishing those priorities; and (5) serves as a nidus for the development of actual clinical trials, the results of which should have important health implications for the hemisphere. Leaders of the National Cancer Institute in Chile have committed to support this conference. Three similar institutes (in Mexico, Peru and Colombia) have joined SWOG through the SWOG Latin American Initiative (SLAI) and have begun to collaborate with their US colleagues and counterparts, and Chile has recently expressed interest in joining SWOG. The goal of the research presented at the conference is to strengthen current collaborations and build novel initiatives in the areas of prevention, treatment and symptom management of common cancer problems in the region. We plan to uncover unique obstacles that limit oncology clinical trials and inspire novel solutions to overcome them, to fully understand the cancer burden in South America and how it relates to research programs in the US, and to help in the development of specific cancer clinical trials.

概括 这次会议的目的是支持一个高质量的科学论坛，以解决 南美的癌症负担旨在产生研究以解决这一负担，并与 可能概括且适用于美国西班牙裔和美洲原住民的结果 人口不足的人口将受到调查员 来自东道国，南美其他地区以及墨西哥和美国的专家 与Healthcare一起的肿瘤学临床的设计，接触和分析 专业人士和研究所领导人在南部的一个东道国举行会议 美国，熟悉一个计划：（1）确定南美和 探索哪些问题是该集合的雄我们 它也适用于美国西班牙裔和美国原住民的讨论； 该地区临床试验的基础设施，机会和挑战 与美国的协作试验 （3）中的机构试验； 和分析；（4）优先考虑协作项目 完成这些优先事项；（5） 试验，其显示的结果对 智利国家癌症研究所的半球领导人已承诺 会议。 Swog Latin American倡议（SLAI），并已开始与他们的美国合作 同事和智利最近表示有兴趣加入Swog 会议上提出的研究的目标是加强当前的合作和 在预防，治疗和症状管理领域建立新的Initiativeves 该地区常见的癌症问题。 肿瘤学临床试验并激发新的解决方案以克服它们，以充分理解您 南美的癌症负担及其与研究计划的关系 在特定癌症临床试验的发展中。